Recurrent anomalies of the short arm of chromosome 9, includin 6-40% of cases (0-83% in T cell ALL and 6-22% in B ing interstitial deletions and translocations, have often been cell ALL). 17 In other hematologic malignancies: acute myeloid 
Introduction
Bone marrow (BM) or peripheral blood (PB) samples were obtained from newly diagnosed ALL (121 cases), AML (85 Cyclin-dependent-kinases (CDKs) play a key role in the concases) and B-CLL (42 cases). Diagnosis was established trol of the cell cycle in eukaryotes.
1,2 Their sequential actiaccording to the standard French-American-British (FAB) crivation and the consequent phosphorylation of critical subteria. Cell suspension immunophenotypic studies were perforstrates stimulate progression through the cell cycle. In med using a panel of lineage-specific monoclonal antibodies. particular, G 1 phase is positively regulated by CDK4/6-cyclin In all samples, tumor cells represented more than 80% of the D and CDK2-cyclin E complexes. Based upon sequence homnucleated cells. ology, two classes of CDK activity inhibitors (CDIs) have been identified these last years: one class includes P15, P16, P18 and P19 genes, P21 and P27 form another class. P16 Cytogenetic studies (INK4A/MTS1) and P15 (INK4B/MTS2) inhibit CDK4/CDK6 activity, 3,4 P21 and P27 inhibit CDK2/CDK4 activity. [5] [6] [7] With Tumoral cells isolated from BM or PB were analyzed using R regard to their function, CDIs can be considered as tumor supbanding after 24-or 48-h unstimulated cultures. The karyopressor genes. 8 The organization of the INK4A and INKB locus types were established according to the International System is represented in Figure 1 . The INK4A locus contains four for Human Cytogenetic Nomenclature. 21 exons that could give rise to two transcripts and two unrelated proteins. [9] [10] [11] P16 is encoded by exons E1␣, E2 and E3, 12 and P19
ARF by a different 5′ exon (E1␤) plus the same exons E2 and E3. 13 P16 and P15 locus which lie closely on chromosome 9p21, are inactivated by deletion or less frequently by 
Southern blot analysis
High molecular weight DNA was extracted from mononuclear cells obtained from PB or BM samples after isolation by FicollHypaque centrifugation. After digestion with XbaI, HindIII and SacI, DNA fragments were separated by electrophoresis in 0.8% agarose gel according to standard procedure. DNA loading was verified by visual inspection of ethidium-stained gels and by hybridization of stripped blots to chromosome 19p13 (R13/19) and 3q27 (LAZ3/BCL6) probes (gift from C Bastard, Rouen, France). These probes were chosen because chromosome 3 and 19 are exceptionally involved in numerical anomalies frequently encountered in leukemias and especially in ALL.
P15, P16 and P27 probes used in this study consist of polymerase chain reaction (PCR)-amplified human DNA segments encompassing nucleotides 6 to 142 on the P16 exon 1␣ sequence (5′ P16 probe, Figure 1 ), nucleotides 702 to 898 on the P16 exon 3 sequence (3′ P16 probe), 3 nucleotides 35 to 218 on the P15 sequence (P15 probe) 4 and nucleotides 216 to 396 on the P27 sequence. 7 There is no sequence homology the TAL-1 gene probe (pG26.5) was kindly provided by O Bernard (IGM, Paris, France) and consists of a 5 kb DNA fragment. Probes ␣-32 P-labelling, prehybridization, hybridization and washing were carried out as previously described. 22 Monoallelic P16 deletion has only been observed in three cases. In some monoallelic cases, a frameshift mutation was found on the remaining allele. 27, 31 Figures 2 and 3 , respectively. Data are summarized in Table 1 . P16 inactivation by deletion and/or rearrangegenetic alteration in this pathology. 33 Finally, search for P27 and P21 deletion was negative in B/T-ALL cases and monoments were found in 25 of 38 T-ALLs (66%) and in 28 of 83 Blineage ALLs (34%). There is no significant difference between allelic deletions of P27 were found in four (5%) AML cases (one AML-M4, one AML-M6, one AML-M7 and one AMLadults and children in this study. Homozygous P16 deletions are significantly more frequent in T-ALLs than in B-lineage M8) (data not shown). In three of these cases, anomalies of chromosome 12p were observed: del(12p) in two cases and ALLs (P Ͻ 0.001). This distribution may reflect a different tumor suppressor activity of the P16 gene with respect to the monosomy 12 in one case. So, P16 inactivation is the most prevalent genetic defect found in ALLs. lymphoid lineages. The frequency of P16 inactivation previously reported in T-ALLs varies from 0% 23 to 83-95%. 24, 25 Out of 40 ALLs with P16 defect, P15 biallelic deletions were observed in 22 cases (55%) and monoallelic deletions A similar incidence to the one we report here was observed in 22 German childhood T-ALLs (77%) 26 and in 59 French Tin 11 cases (28%). P15 deletion when observed was always accompanied by a P16 anomaly. It is then expected that P16 ALL patients (76%). 27 A lower frequency has been reported in French T-ALL patients (25%), 28 in Japanese child T-ALL cases rather than P15 is the target of 9p deletions in ALL. However, we cannot exclude that P15 played a predominant role in (39-46%), 29, 30 and in Swedish child T-ALL cases (64%). 31 Such results may be due to a sampling or methodological bias, some ALL where it was found inactivated without deletion of P16. 31 but also to differences according to the geographic or ethnic origins of patients.
In eight cases (three T-ALL and five B-lineage ALL), South- ventional cytogenetics to detect subtle chromosome aberrations and the necessity to perform molecular biology in such situations. It is worth noting that in two patients carrying a translocation between 9p21 and another chromosome, the P16/P15 locus was in germline configuration, suggesting the presence in 9p21 of other gene(s) involved in leukemogenesis.
In an attempt to correlate deletion of P15/P16 with other known molecular anomalies in leukemia we carried out Southern blot analysis of the TAL-1 locus which is frequently involved in T-ALLs. 34 It was found rearranged in eight of 28 and in B-CLL (0%). Prognostic incidence of P16 alteration in children could not be performed because of too short a follow-up. In adult, study ern blot analysis showed rearrangement of P16 locus. In six of the survival curves in 25 patients including all T-ALL and cases (Nos 17, 27, 47, 48, 70 and 88) one allele was deleted B-lineage ALLs with a standard risk (CD10 + , absence of Ph1 and the other rearranged. In one case (No. 35), one allele was and 11q23 anomalies, leukocytes Ͻ30 Giga/l, age Ͻ35 years) rearranged and the other was in germline configuration. In indicate that P16 inactivation might be of prognostic value the remaining case (No. 85) both alleles were found to be (P = 0.05, data not shown). However, as the patients were not rearranged. In one of these cases (No. 47), rearrangement may treated on a consistent protocol, and because of the small result from a t(1;9)(q23;p21) which was detected in the tumosample size of the ALLs included in this study, these results ral cells. Restriction mapping analysis allowed us to determine must be confirmed by further studies in a large group of unithat breakpoints may occur either within the P16 locus formly treated patients. The same reserve goes for previous between exons E1␣ and E3 (cases 17, 27, 48 and 88) or studies which led to similar conclusions.
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between P16 exon 1␣ and P15 exon 2 (cases 35, 47, 70 and 85). These two DNA segments have been previously identified as two major breakpoint clusters occurring in T-ALLs. 27 We Acknowledgements show here that in B-lineage ALLs, the same situation is observed. Furthermore, it is to be noted that in four of five BThis work was supported by grants from Ligue Contre le lineage ALLs, breakpoints are located between P16 and P15 Cancer (Comité National, Comité de l'Yonne, Comité du locus. Indeed, this peculiar association must be confirmed by Rhône), ARC (6741) and Hospices Civils de Lyon. We thank study of a larger number of cases.
B Santaluccia and MH Teillon-Berranger for excellent techniThe presence or absence of P19 ARF has not been analyzed, cal assistance. but it is likely to be inactivated in the cases where both P16/P15 were deleted (exon E1␤ included) and when breakpoints occurred within the P16 locus.
Cytogenetic analysis, performed in 104 cases, was normal References in 22 cases. Twelve patients had chromosome 9p anomalies,
